-
-
-
-
-
-
-
Longeveron receives Canadian patent for stem cell treatments
-
-
-
-
-
-
-
Longeveron (LGVN) Completes Enrollment of Pivotal Phase 2b Trial of Laromestrocel
-
-
-
-
-
-
-
Longeveron (LGVN) Announces Positive Type C Meeting with FDA Regarding Pathway to BLA for Lomecel-B
-
-
-
-
-
-
487,365 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


